PharmiWeb.com - Global Pharma News & Resources
15-Jul-2019

Stretch Marks Treatment Market Size Poised to Touch USD 4 Billion by 2026

The Global Stretch Marks Treatment Market Size is anticipated to around USD 4 billion by 2026, this market is anticipated to grow with 7.7% CAGR during the forecast time period 2019 to 2026.

The expansion of the worldwide market for therapy of stretch marks is being encouraged by increasing numbers of people in various ages. The increased incidence of obesity as a result of the increasing consumption and inactive living standards of calorie-loaded fatty foods are a leading cause for stretch marks. The demand for extended mark therapy is growing, such as increased awareness among pregnant females who are highly susceptible to stretch marks, urbanization and skilled manufacturers ' advertising.

One of the most significant elements of increasing interest among people with regard to the aesthetic appearance is that of an increasing demand for the therapy of stretch marks. The treatment of various types of scars promotes a full restoration of skin that promotes an individual's aesthetic appearance. People therefore choose to treat stretch marks mainly because of their greater interest in the look of females. This population is therefore expected to be the leading player in the therapy of stretch marks. The lifestyles of people and increasing disposable earnings are also evolving factors which drive demand for the therapy industry for stretch marks.

Download Free Sample Report Pages at https://www.acumenresearchandconsulting.com/request-sample/1511

The growing impacts of the stretch marks are driving the development of the world market for therapy of stretch marks. Furthermore, the increasing incidence of obesity in the worldwide and developing world as a result of fast foods and changing eating patterns drives worldwide development. In addition, individuals have a global evolving lifestyle as a result of growing disposable income owing to urbanization and industrialisation. This has resulted to increased worries about private esthetics and the treatment of stretch marks. Moreover, the social media and simple access to data on the internet have appeared owing to the increased penetration of the internet. The knowledge of the accessibility of efficient medicines has led in his factor. These variables favor the development of the worldwide market for therapy of stretch marks. Moreover, booming international e-commerce platforms make efficient medicines worldwide accessible that benefits the development of the worldwide market in the therapy of stretch marks. However, the costly development of the worldwide therapy industry is limited for certain medicines in some cost-sensitive fields. Fear of possible side effects, such as rashes and itchiness, on the skin and in other areas, further restricted the development of the worldwide therapy of stretch marks.

In the stretch marks therapy industry, North America is expected to predominate. It is estimated that over one third of the total market for therapy of stretch marks is in the region. In comparison to the other emerging areas, Latin America will emerge as the largest increasing marketplace. Despite continuing economic downturn in the area, Europe's therapy market for stretched marks is expected to develop at a decent pace in the future. The rapid aging population in the region is expected to stimulate the growth of the economy in Europe in the years to come.

Key Players amp; Strategies

The prominent market players include Union-Swiss (Pty) Ltd.; Merz North America, Inc.; Syneron Medical Ltd.; E.T. Browne Drug Co., Inc.; Cynosure, Inc.; Dermaclara, Inc.; Laboratoires Expanscience; Clarins Group; Centre Light Solutions, LLC; Ellipse A / S; The Boppy Company LLC; Mama Mio US, Inc.; Helix BioMedix, Inc.; and Weleda AG. These players are focusing on adopting growth strategies, such as partnerships, innovations, and new product launches, among others. Clarins Group has lately entered Plastic Odyssey as one of its main players for the introduction of green products and other technologies.

View Detail Information at https://www.acumenresearchandconsulting.com/stretch-marks-treatment-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Stretch Marks Treatment
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Stretch Marks Treatment Market By Treatment
1.2.2.1. Global Stretch Marks Treatment Market Revenue and Growth Rate Comparison By Treatment (2015-2026)
1.2.2.2. Global Stretch Marks Treatment Market Revenue Share By Treatment in 2017
1.2.2.3. Microdermabrasion
1.2.2.4. Topical products
1.2.2.4.1. Oils
1.2.2.4.2. Creams
1.2.2.4.3. Lotion
1.2.2.5. Laser
1.2.2.5.1. Pulse-Dye Laser
1.2.2.5.2. Fractional Laser
1.2.2.5.3. Others
1.2.3. Stretch Marks Treatment Market By End Use
1.2.3.1. Global Stretch Marks Treatment Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.3.2. Global Stretch Marks Treatment Market Revenue Share By End Use in 2017
1.2.3.3. Hospitals
1.2.3.4. Clinics
1.2.3.5. Others
1.2.4. Stretch Marks Treatment Market by Geography
1.2.4.1. Global Stretch Marks Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Stretch Marks Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Stretch Marks Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Stretch Marks Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Stretch Marks Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Stretch Marks Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Stretch Marks Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Stretch Marks Treatment Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Stretch Marks Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Stretch Marks Treatment Major Manufacturers in 2017

CHAPTER 4. STRETCH MARKS TREATMENT MARKET BY TREATMENT

4.1. Global Stretch Marks Treatment Revenue By Treatment
4.2. Microdermabrasion
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Topical products
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Oils
4.3.4. Creams
4.3.5. Lotion
4.4. Laser
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.3. Pulse-Dye Laser
4.4.4. Fractional Laser
4.4.5. Others

CHAPTER 5. STRETCH MARKS TREATMENT MARKET BY END USE

5.1. Global Stretch Marks Treatment Revenue By End Use
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Clinics
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA STRETCH MARKS TREATMENT MARKET BY COUNTRY

6.1. North America Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Stretch Marks Treatment Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE STRETCH MARKS TREATMENT MARKET BY COUNTRY

7.1. Europe Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC STRETCH MARKS TREATMENT MARKET BY COUNTRY

8.1. Asia-Pacific Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA STRETCH MARKS TREATMENT MARKET BY COUNTRY

9.1. Latin America Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST STRETCH MARKS TREATMENT MARKET BY COUNTRY

10.1. Middle East Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA STRETCH MARKS TREATMENT MARKET BY COUNTRY

11.1. Africa Stretch Marks Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Stretch Marks Treatment Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Basq Skincare
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Union-Swiss (Pty) Ltd.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Merz North America, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Syneron Medical Ltd.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. E.T. Browne Drug Co., Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Cynosure, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Dermaclara, Inc.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Laboratoires Expanscience
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Clarins Group
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Centre Light Solutions, LLC
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Ellipse A / S
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. The Boppy Company LLC
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Mama Mio US, Inc.
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Helix BioMedix, Inc.
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. Weleda AG.
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Others
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Request for Customization at https://www.acumenresearchandconsulting.com/request-customization/1511

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1511

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 15-Jul-2019